News

People with longer-term COVID-19 symptoms showed reduced performance in tasks testing different mental processes up to two years after infection.

An autoproteolytic, transmembrane signaling process thought to be exclusive to eukaryotes has been identified in a bacterial species, Clostridium thermocellum.

New research findings suggest that active compounds released by microorganisms have great potential for use in oil spills in the North Sea or similar ocean habitats.

Researchers have discovered the molecular mechanisms by which the human immunodeficiency virus (HIV) becomes resistant to Dolutegravir, one of the most effective, clinically used antiviral drugs for treating HIV.

The new sensor design resembles a molecular toolbox that can be used to quickly assemble sensors for a variety of purposes.

The pathogens that cause urinary tract infections are becoming increasingly resistant to antibiotics. ETH Zurich researchers have now developed a rapid test and a new therapeutic approach using bacteria-​infecting viruses known as phages.

Toxic shock syndrome is associated with a life-threatening reaction from the immune system. Probiotics may help prevent the disease before the cytokine cascade ever begins.

A new mRNA vaccine targeting immune cells in the liver could be the key to tackling malaria, a disease that causes over half a million deaths each year according to the World Health Organization, yet has no effective long-lasting vaccine.

Adversity experienced by mothers during their childhood or pregnancy is reflected in their children’s gut microbiomes, a recent study found.

Priming crop plants with a microbe sourced from the roots of desert plants could be a powerful tool to boost crop plant's resilience to drought.